Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Change in Acquisitions & Divestments (2016)

Historic Change in Acquisitions & Divestments for Aytu Biopharma (AYTU) over the last 1 years, with Q2 2016 value amounting to $1.0 million.

  • Aytu Biopharma's Change in Acquisitions & Divestments changed N/A to $1.0 million in Q2 2016 from the same period last year, while for Jun 2016 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2017, which is 291.4% up from last year.
  • Aytu Biopharma's Change in Acquisitions & Divestments amounted to $1.0 million in Q2 2016.
  • Over the past 5 years, Aytu Biopharma's Change in Acquisitions & Divestments peaked at $1.0 million during Q2 2016, and registered a low of $1.0 million during Q2 2016.